Found 0 matching trials
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease PHASE1 Background:
\- Hydroxypropyl beta cyclodextrin (HPBCD) is being tested for...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Open-label Study of VTS-270 in Participants With Neurologic Manifestations of Niemann-Pick Type C1 PHASE2 This is a multicenter, multinational, open-label study of VTS-270 to evalua...
Show More Location
Hospital Clinica Biblica
Learn More & Join Trial
The Androtriol Injection for the Treatment of Acute Ischemic Stroke PHASE2 This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients PHASE1 This research study is being conducted to find out whether Trappsol® Cyclo™...
Show More Learn More & Join Trial
Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda PHASE2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel cor...
Show More Location
Victoria Biomedical Research Institute
Learn More & Join Trial
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease PHASE2 Due to different study designs, the sponsor separated Part C into this sepa...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial